Screener
Ironwood Pharmaceuticals IRWD Return on equity
Discontinued — last reported Q1 '23
Return on equity at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed May 9, 2024. Open the filing →
- Filed
- May 9, 2024
- Fiscal quarter
- Q1 FY2024
- Calendar quarter
- Q1 2024
- Accession
- 0001558370-24-007640
FAQ
- What is Ironwood Pharmaceuticals's return on equity?
- Ironwood Pharmaceuticals (IRWD) reported return on equity of 29.7% in Q1 2023.
- How has Ironwood Pharmaceuticals's return on equity changed year-over-year?
- Ironwood Pharmaceuticals's return on equity decreased by 82.3% year-over-year, from 167.9% to 29.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Ironwood Pharmaceuticals's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude